UPDATED: Watching GRI Bio; Zacks Investment Research Upgrades Stock To Buy

Benzinga News-desk www.benzinga.com Neutral 92.3%

Neg 0% Neu 92.3% Pos 0%

https://www.zacks.com/stock/news/2989341/gri-bio-inc-gri-upgraded-to-buy-what-does-it-mean-for-the-stock

Comments

No comments yet. Be the first!